Table 3. Expression levels and related functions of the six selected human miRNAsa.
| miRNA | Discovery stage: FCb |
Validation stagec |
Relevant functions | Sources | |||||
|---|---|---|---|---|---|---|---|---|---|
| CBP/Non | CBP/Exp | Exp/Non | CBP/Non | CBP/Exp | Exp/Non | ||||
| let-7d-5p | −1.21 | −0.71 | −0.50 | 0.25 (0.12, 0.55) | 0.30 (0.15, 0.67) | 0.49 (0.15,0.97) | RAS regulation; regulation of iron metabolism in erythroid cells | (19,20) | |
| miR-24-3p | 1.50 | 1.87 | −0.37 | 3.52 (1.85, 5.94) | 3.31 (1.74, 5.59) | 0.69 (0.35, 1.22) | PAHs response; DNA damage response; ARNT regulation | (13) | |
| miR-122-5p | −1.99 | −1.22 | −0.76 | 0.07 (0.03, 0.09) | 0.12 (0.06, 0.16) | 0.32 (0.18, 0.51) | Heme oxygenase-1 regulation | (21) | |
| miR-221-3p | 1.15 | 2.16 | −1.01 | 3.96 (1.77, 8.05) | 11.92 (5.33, 24.23) | 0.23 (0.14, 0.45) | low-level hydroquinone response | (22) | |
| miR-223-3p | −0.83 | −1.17 | 0.35 | 0.52 (0.18, 1.37) | 0.34 (0.11, 0.88) | 0.59 (0.36, 1.77) | Environmental cigarette smoke (ECS) response | (21) | |
| miR-638 | −1.07 | −2.08 | 1.01 | 0.20 (0.13, 0.42) | 0.06 (0.04, 0.12) | 2.20 (0.89, 4.98) | Benzo(a)pyrene response; regulation of differentiation and proliferation in leukemic cells | (23,24) | |
a, Non = non-exposure and Exp = Exposure; b, the fold change value underwent a Log2-transformation; c, values are median (25th percentile, 75th percentile) qRT-PCR expression relative to cel-miR-238. qRT-PCR, quantitative reverse-transcription polymerase chain reaction.